Advertisement

Topics

Axim Biotech Enters Clinical Study Agreement With University of British Columbia To Begin Clinical Trial On CBD Chewing Gum For Treatment Of Drug-Related Psychosis

20:00 EDT 1 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Axim Biotech Enters Clinical Study Agreement With University of British Columbia To Begin Clinical Trial On CBD Chewing Gum For Treatment Of Drug-Related Psychosis

NEXT ARTICLE

More From BioPortfolio on "Axim Biotech Enters Clinical Study Agreement With University of British Columbia To Begin Clinical Trial On CBD Chewing Gum For Treatment Of Drug-Related Psychosis"

Quick Search
Advertisement